论文部分内容阅读
目的研究8BrcAMP对培养的人视网膜母细胞瘤HXORb44细胞癌基因表达的效应及其与该细胞生长的关系。方法cfosmRNA、NmycmRNA及p21rasmRNA均以原位杂交和RNA斑点印迹技术检测,对繁殖细胞核抗原(PCNA)、cFos、NMyc和P21ras蛋白表达的免疫反应性(IR)则采用免疫组化及蛋白质斑点印迹技术检测。结果在人HXORb44细胞,cfosmRNA、NmycmRNA及p21rasmRNA定位于胞质,cFosIR及NMycIR定位于胞核,而P21rasIR则位于胞质。斑点印迹的相对扫描数值显示实验组(8BrcAMP处理)均低于相应各对照组(未经8BrcAMP处理),P<0.05~0.01。结论(1)8BrcAMP可抑制人HXORb44细胞的生长增殖;(2)8BrcAMP可下调cfos、Nmyc及p21ras癌基因的表达;(3)8BrcAMP也可下调cFos、NMyc及P21ras蛋白的表达,而且其变动各与其mRNA基因表达的变动相一致;(4)结果提示8BrcAMP可能从不同的途径而协同抑制HXORb44细胞的生长增殖。
Objective To study the effect of 8BrcAMP on oncogene expression in cultured human retinoblastoma HXORb44 cells and its relationship with the cell growth. Methods c fos mRNA, N mycm RNA and p21rasmRNA were detected by in situ hybridization and RNA dot blot technique. The immunoreactivity (IR) to the expression of proliferating cell nuclear antigen (PCNA), cFos, NMyc and P21ras protein Immunohistochemistry and protein blotting detection. Results In human HXORb44 cells, cfosmRNA, NmycmRNA and p21rasmRNA were located in the cytoplasm, cFosIR and NMycIR were located in the nucleus, whereas P21rasIR was located in the cytoplasm. Dot blot relative scanning values show that the experimental group (8 BrcAMP treatment) were lower than the corresponding control group (without 8 BrcAMP treatment), P <0.05 ~ 0.01. (2) 8BrcAMP down-regulated cfos, Nmyc and p21ras oncogene expression; (3) 8BrcAMP can inhibit the growth and proliferation of human HXORb44 cells; CAMP also down-regulated c-Fos, N-Myc and P21ras protein expression, and its changes were consistent with the changes of its mRNA gene expression; (4) The results suggest that 8 BrcAMP may synergistically inhibit HXO from different ways Rb44 cell growth and proliferation.